부산대학교 도서관

Pander, Jan; Wessels, Judith AM; Mathijssen, Ron HJ; Gelderblom, Hans; Guchelaar, Henk-Jan

Pharmacogenomics. July, 2010, Vol. 11 Issue 7, p1011, 7 p.

PLUKKER, JT; VANOORT, [No Value]; VERMEY, A; MOLENAAR, [No Value]; HOEKSTRA, HJ; PANDERS, AK; DOLSMA, WV; KOOPS, HS

Journal of British Surgery. 82:510-514

deKok, YJM; Vossenaar, E; Cremers, C; Dahl, N; Laporte, J; Hu, L; Lacombe, D; Fischel-Ghodsian; Friedman, R; Parnes, L; Thorpe, P; Malcolm, S; Pander, HJ; Heilbronner, H; Gravelin, J; den Dunnen, J; Brunner, HG; Ropers, HH; Cremers, FPM

Hum Mol Genet. 5:1229

Gallon R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. Electronic address: richard.gallon@newcastle.ac.uk.; Phelps R; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Hayes C; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Brugieres L; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Guerrini-Rousseau L; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France; Team 'Genomics and Oncogenesis of pediatric Brain Tumors,' INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Colas C; Département de Génétique, Institut Curie, Paris, France; INSERM U830, Université de Paris, Paris, France.; Muleris M; Sorbonne Université, Institut National de la Santé et de la Recherche Médicale, Centre de Recherche Saint-Antoine, Paris, France.; Ryan NAJ; The Academic Women's Health Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Department of Gynaecology Oncology, Royal Infirmary of Edinburgh, Edinburgh, UK.; Evans DG; Division of Evolution, Infection and Genomics, University of Manchester, Manchester, UK.; Grice H; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Jessop E; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Kunzemann-Martinez A; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK; Centre for Inflammation and Tissue Repair, University College London, London, UK.; Marshall L; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Schamschula E; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Oberhuber K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Azizi AA; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Baris Feldman H; The Genetics Institute and Genomics Center, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Beilken A; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.; Brauer N; Pediatric Oncology, Helios-Klinikum, Krefeld, Germany.; Brozou T; Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children's Hospital, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.; Dahan K; Centre de Génétique Humaine, Institut de Pathologie et Génétique, Gosselies, Belgium.; Demirsoy U; Department of Pediatric Oncology, Kocaeli University, Kocaeli, Turkey.; Florkin B; Department of Pediatrics, Citadelle Hospital, University of Liège, Liège, Belgium.; Foulkes W; Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada; Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.; Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantation Medical University, Poznan, Poland.; Jones KJ; Department of Clinical Genetics, Western Sydney Genetics Program, Children's Hospital at Westmead, Sydney, New South Wales, Australia; University of Sydney School of Medicine, Sydney, New South Wales, Australia.; Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.; Lobitz S; Gemeinschaftsklinikum Mittelrhein, Department of Pediatric Hematology and Oncology, Koblenz, Germany.; Meade J; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; Nathrath M; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany; Department of Pediatrics, Pediatric Oncology Center, Technische Universität München, Munich, Germany.; Pander HJ; Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany.; Perne C; Institute of Human Genetics, Medical Faculty, University of Bonn and National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.; Ragab I; Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.; Rosenbaum T; Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany.; Rueda D; Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain.; Sarosiek T; Department of Oncology, Luxmed Onkologia, Warsaw, Poland.; Sehested A; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.; Spier I; Institute of Human Genetics, Medical Faculty, University of Bonn and National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.; Suerink M; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Zimmermann SY; Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital, Frankfurt, Germany.; Zschocke J; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Borthwick GM; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Wimmer K; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Burn J; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Jackson MS; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.; Santibanez-Koref M; Biosciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.

Publisher: W.B. Saunders Country of Publication: United States NLM ID: 0374630 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0012 (Electronic) Linking ISSN: 00165085 NLM ISO Abbreviation: Gastroenterology Subsets: MEDLINE

Gallon R; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Mühlegger B; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Wenzel SS; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Sheth H; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Hayes C; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Aretz S; Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany.; Dahan K; Centre de génétique humaine, Institut de pathologie et génétique (IPG), Gosselies, Belgium.; Foulkes W; Program in Cancer Genetics, Departments of Oncology and Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.; Kratz CP; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.; Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.; Azizi AA; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Baris Feldman H; The Genetics Institute, Rambam Health Care Campus, and The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.; Chong AL; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.; Department of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.; Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Quebec, Canada.; Demirsoy U; Department of Pediatric Oncology, Kocaeli University, Kocaeli, Turkey.; Florkin B; Department of Pediatrics, CHR Citadelle Hospital, University of Liège, Liège, Belgium.; Imschweiler T; Pediatric Oncology, Helios-Klinikum, Krefeld, Germany.; Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantation, Poznań University of Medical Sciences, Poznań, Poland.; Lobitz S; Department of Pediatric Oncology/Pediatric Hematology, Kliniken der Stadt Köln gGmbH, Children's Hospital Amsterdamer Strasse, Köln, Germany.; Nathrath M; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany.; Department of Pediatrics, Pediatric Oncology Center , Technische Universität München, Munich, Germany.; Pander HJ; Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany.; Perez-Alonso V; Pediatrics Department, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain.; Perne C; Institute of Human Genetics, Biomedical Centre, University Hospital Bonn, Bonn, Germany.; Ragab I; Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Rosenbaum T; Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany.; Rueda D; Hereditary Cancer Laboratory, University Hospital Doce de Octubre, i+12 Research Institute, Madrid, Spain.; Seidel MG; Research Unit Pediatric Hematology and Immunology, Division of Pediatric Hematology-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria.; Suerink M; Department of Clinical Genetics, Leiden University Medical Center, Leiden, Netherlands.; Taeubner J; Department of Pediatric Oncology, Hematology and Clinical Immunology, University Children´s Hospital, Medical Faculty, Heinrich Heine University, Duesseldorf, Germany.; Zimmermann SY; Department of Pediatric Hematology and Oncology, Children's Hospital, University Hospital, Frankfurt, Germany.; Zschocke J; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.; Borthwick GM; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Burn J; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Jackson MS; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Santibanez-Koref M; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.; Wimmer K; Division of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9215429 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-1004 (Electronic) Linking ISSN: 10597794 NLM ISO Abbreviation: Hum Mutat Subsets: MEDLINE

Pander J; Gelderblom H; Antonini NF; Tol J; van Krieken JHJ; van der Straaten T; Punt CJA; Guchelaar HJ

European Journal of Cancer (EUR J CANCER), Jul2010; 46(10): 1829-1834. (6p)

Yntema, HG; van den Helm, B; Kissing, J; van Duijnhoven, G; Poppelaars, F; Chelly, J; Moraine, C; Fryns, JP; Hamel, BCJ; Heilbronner, H; Pander, HJ; Brunner, HG; Ropers, HH; Cremers, FPM; van Bokhoven, H

GENOMICS; DEC 15 1999, 62 3, p332-p343, 12p.

González-Acosta M; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Marín F; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Puliafito B; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Bonifaci N; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Fernández A; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Navarro M; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Salvador H; Pediatric Oncology Unit, Hospital Sant Joan de Déu, Esplugues, Barcelona, Spain.; Balaguer F; Department of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.; Iglesias S; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Velasco A; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Institut d'Investigació Biomèdica de Girona - IDIBGI, Girona, Spain.; Grau Garces E; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Moreno V; Cancer Prevention and Control Program, Catalan Institute of Oncology - ICO, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, CIBERESP, L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain.; Gonzalez-Granado LI; Immunodeficiencies Unit, Department of Pediatrics, Doce de Octubre University Hospital, i+12 Research Institute; Complutense University of Madrid, Madrid, Spain.; Guerra-García P; Hematology and Oncology Unit, Department of Pediatrics, Doce de Octubre University Hospital, Madrid, Spain.; Ayala R; Department of Hematology, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.; Florkin B; University Department of Pediatrics, CHR Citadelle, Liege, Belgium.; Kratz C; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.; Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.; Rosenbaum T; Department of Pediatrics, Sana Kliniken Duisburg, Duisburg, Germany.; Januszkiewicz-Lewandowska D; Department of Pediatric Oncology, Hematology and Transplantation, Poznań University of Medical Sciences, Poznań, Poland.; Azizi AA; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Ragab I; Pediatrics Department, Hematology-Oncology Unit, Faculty of Medicine, Ain Shams University, Cairo, Egypt.; Nathrath M; Pediatric Hematology and Oncology, Klinikum Kassel, Kassel, Germany.; Pediatric Oncology Center, Department of Pediatrics, Technische Universität München, Munchen, Germany.; Pander HJ; Institut für Klinische Genetik, Olgahospital, Stuttgart, Germany.; Lobitz S; Department of Pediatric Oncology/Pediatric Hematology, Kliniken der Stadt Köln gGmbH, Children's Hospital Amsterdamer Strasse, Koln, Germany.; Suerink M; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.; Dahan K; Centre de Génétique Humaine, Institut de Pathologie et de Génétique (IPG), Gosselies, Belgium.; Imschweiler T; Pediatric Oncology, Helios-Klinikum, Krefeld, Germany.; Demirsoy U; Department of Pediatric Oncology, Kocaeli Universitesi, Kocaeli, Turkey.; Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Institut d'Investigació Biomèdica de Girona - IDIBGI, Girona, Spain.; Lázaro C; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain.; Rueda D; Hereditary Cancer Laboratory, Doce de Octubre University Hospital, i+12 Research Institute, Madrid, Spain.; Wimmer K; Division of Human Genetics, Medical University Innsbruck, Innsbruck, Austria.; Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain gcapella@iconcologia.net mpineda@iconcologia.net.; Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology - ICO, Hereditary Cancer Group, Molecular Mechanisms and Experimental Therapy in Oncology Program, Institut d'Investigació Biomèdica de Bellvitge - IDIBELL, Ciber Oncología (CIBERONC) - Instituto de Salud Carlos III, L'Hospitalet de Llobregat, Barcelona, Spain gcapella@iconcologia.net mpineda@iconcologia.net.

Publisher: British Medical Association Country of Publication: England NLM ID: 2985087R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-6244 (Electronic) Linking ISSN: 00222593 NLM ISO Abbreviation: J Med Genet Subsets: MEDLINE

Dork, T; Dworniczak, B; AulehlaScholz, C; Wieczorek, D; Bohm, I; Mayerova, A; Seydewitz, HH; Nieschlag, E; Meschede, D; Horst, J; Pander, HJ; Sperling, H; Ratjen, F; Passarge, E; Schmidtke, J; Stuhrmann, M

HUMAN GENETICS; SEP 1997, 100 3-4, p365-p377, 13p.

deKok, YJM; Vossenaar, ER; Cremers, CWRJ; Dahl, N; Laporte, J; Hu, LJ; Lacombe, D; FischelGhodsian, N; Friedman, RA; Parnes, LS; Thorpe, P; BitnerGlindzicz, M; Pander, HJ; Heilbronner, H; Graveline, J; denDunnen, JT; Brunner, HG; Ropers, HH; Cremers, FPM

HUMAN MOLECULAR GENETICS; SEP 1996, 5 9, p1229-p1235, 7p.

Pander HJ; Schwinger E

Publisher: Cell Press Country of Publication: United States NLM ID: 0370475 Publication Model: Print Cited Medium: Print ISSN: 0002-9297 (Print) Linking ISSN: 00029297 NLM ISO Abbreviation: Am J Hum Genet Subsets: MEDLINE

Pander HJ; Institut für Klinische Genetik Olgahospital-Städtische Frauenklinik Obere Str. 2 70190 Stuttgart.

Publisher: Schmidt-Romhild Country of Publication: Germany NLM ID: 8305989 Publication Model: Print Cited Medium: Print ISSN: 0723-2276 (Print) Linking ISSN: 07232276 NLM ISO Abbreviation: Kinderkrankenschwester

de Kok YJ; Department of Human Genetics, University Hospital Nijmegen, The Netherlands.; Vossenaar ER; Cremers CW; Dahl N; Laporte J; Hu LJ; Lacombe D; Fischel-Ghodsian N; Friedman RA; Parnes LS; Thorpe P; Bitner-Glindzicz M; Pander HJ; Heilbronner H; Graveline J; den Dunnen JT; Brunner HG; Ropers HH; Cremers FP

Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9208958 Publication Model: Print Cited Medium: Print ISSN: 0964-6906 (Print) Linking ISSN: 09646906 NLM ISO Abbreviation: Hum Mol Genet Subsets: MEDLINE

Vervloet MG; Nephrology Department, Amsterdam UMC, Amsterdam, The Netherlands. m.vervloet@amsterdamumc.nl.; de Jong HJ; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.; Pander J; Evidence Generation Lead, AstraZeneca BV, The Hague, The Netherlands.; Overbeek JA; PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands.

Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE

Pander J; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, The Netherlands; PO box 9600, 2300 RC Leiden, The Netherlands.; van Huis-Tanja L; Department of Clinical Oncology, Leiden University Medical Center, The Netherlands; PO box 9600, 2300 RC Leiden, The Netherlands.; Böhringer S; Department of Biostatistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands.; van der Straaten T; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, The Netherlands; PO box 9600, 2300 RC Leiden, The Netherlands.; Gelderblom H; Department of Clinical Oncology, Leiden University Medical Center, The Netherlands; PO box 9600, 2300 RC Leiden, The Netherlands.; Punt C; Department of Medical Oncology, Academic Medical Center Amsterdam, The Netherlands; PO Box 22660, 1100 DD Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, The Netherlands; PO box 9600, 2300 RC Leiden, The Netherlands.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Pander J; Gelderblom H; van der Straaten T; Punt CJ; Guchelaar HJ

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Pander J; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Heusinkveld M; van der Straaten T; Jordanova ES; Baak-Pablo R; Gelderblom H; Morreau H; van der Burg SH; Guchelaar HJ; van Hall T

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Pander J; Department of Clinical Pharmacy & Toxicology.; Wessels JAM; Department of Clinical Pharmacy & Toxicology.; Gelderblom H; Department of Clinical Oncology, Leiden University Medical Center, Leiden.; van der Straaten T; Department of Clinical Pharmacy & Toxicology.; Punt CJA; Department of Medical Oncology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy & Toxicology. Electronic address: h.j.guchelaar@lumc.nl.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Pander J; Leiden University Medical Center, Department of Clinical Oncology, PO Box 9600, 2300RC Leiden, the Netherlands. a.j.gelderblom@lumc.nl; Guchelaar HJ; Gelderblom H

Publisher: Thomson Reuters (Scientific) Ltd Country of Publication: England NLM ID: 100891485 Publication Model: Print Cited Medium: Internet ISSN: 2040-3445 (Electronic) Linking ISSN: 14648431 NLM ISO Abbreviation: Curr Opin Mol Ther Subsets: MEDLINE

Pander J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, PO Box 9600, NL 2300 RC Leiden, The Netherlands.; Gelderblom H; Guchelaar HJ

Publisher: Elsevier Science Ltd. Country of Publication: England NLM ID: 9604391 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1359-6446 (Print) Linking ISSN: 13596446 NLM ISO Abbreviation: Drug Discov Today Subsets: MEDLINE